Ranger Biotechnologies A/S — Credit Rating and Financial Key Figures

Ranger Biotechnologies A/S (CVR number: 32280404) is a company from ODENSE. The company recorded a gross profit of 1653.8 kDKK in 2023. The operating profit was 1428.5 kDKK, while net earnings were 1431.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 52.5 %, which can be considered excellent and Return on Equity (ROE) was 72.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 96.9 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Ranger Biotechnologies A/S's liquidity measured by quick ratio was 22.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.